← Open Payments lookup

STEVE KLINE: Open Payments

NPI 1912763137 · CLEBURNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,828 in 145 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,106 · 2025 $1,828

Food & beverage: $1,828
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)31$392
Alkermes, Inc.14$368
ABBVIE INC.19$259
Otsuka America Pharmaceutical, Inc.11$240
E.R. Squibb & Sons, L.L.C.32$204
Teva Pharmaceuticals USA, Inc.28$170
Lundbeck LLC6$110
Neurocrine BioSciences, Inc.2$39
Janssen Pharmaceuticals, Inc1$26
Supernus Pharmaceuticals, Inc.1$21

Products named: CAPLYTA, VRAYLAR, REXULTI, ARISTADA, COBENFY, LYBALVI, UZEDY, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.